Clavis Pharma and Clovis Oncology Sign $380 Million Partnership deal for Anti-Cancer Agent CP-4126
By Frontier India Pharmacetuicals News | November 24th, 2009 | Category: Medical Company News | No Comments »Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer. CP-4126 is a novel, patented, [...]
